Ompia, Jaime .
HRN: 26-18-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/06/2024
11/20/2024
IV
4.5 G
Q8
Pneumoperitoneum
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes